fda compounded glp-1 is moving to restrict mass-marketed products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified GLP-1 Compounding Crackdown | Double-Helix

Reduced effectiveness despite consistent dosing can also indicate degradation, though this is harder to confirm objectively

adults reported taking a GLP-1 drug (also known as a glucagon-like peptide-1 receptor agonist)

Who Should Avoid It: Individuals with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or active pancreatitis

Checked bags are subject to extreme temperature changes in the cargo hold and are at a much higher risk of being lost or delayed, which could leave you without your medication

Efficacy and Safety of Orforglipron, an Oral Small-Molecule LPp-1 Receptor Agonist, on Cardiometabolic Outcomes: A Meta-Analysis and Systematic Review

Post-accident testing After workplace accidents, employers may require drug testing to determine if impairment contributed